Biotechnology News

July 30, 2014

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for...

July 30, 2014

SEATTLE--(BUSINESS WIRE)--Dendreon Corporation (Nasdaq:DNDN) today announced that its board of directors has appointed W. Thomas Amick as president and chief executive officer, effective immediately. Mr. Amick has also been appointed to the...

July 30, 2014

RICHMOND, Va.--(BUSINESS WIRE)--AIBioTech®, a comprehensive contract research organization, is pleased to announce that it is acting as a subcontractor to Leidos, which was awarded a contract by the U.S. Air Force to provide research, development...

July 30, 2014

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Cold Genesys, Inc., a clinical-stage biopharmaceutical company developing oncolytic immunotherapies for cancer, announced today that it has secured financing of $13.57 million from Ally Bridge Group.

July 30, 2014

SAN FRANCISCO & MEXICO CITY--(BUSINESS WIRE)--Invitae Corporation, a genetic information company, and Nanopharmacia, the leading oncology molecular test provider in Mexico, today announced an exclusive partnership to make Invitae’s genetic...

July 30, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that all proposals were approved at its Annual General Meeting of Shareholders held earlier today. These proposals included the appointment of directors, the...

July 30, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has entered into a new agreement with Medline Industries, Inc. to commercialize the Company’s advanced wound care product - Hyalomatrix®, in the...

July 30, 2014

NORTHBROOK, Ill.--(BUSINESS WIRE)--Marathon Pharmaceuticals, focused on treatments for rare diseases, today announced Jeanine M. Swalec has joined the company as its vice president of regulatory affairs.

July 30, 2014

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical (AZM), has received Shonin approval from the...

July 30, 2014

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. ("Eagle") (Nasdaq:EGRX) today announced that the Company will release its 2014 third quarter financial results on Monday, August 11, 2014, before the market opens. Following...

July 30, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Envisia Therapeutics Bolsters Board of Directors with Key Appointments

July 30, 2014

MILAN--(BUSINESS WIRE)--Sorin Group Announces Results for the Second Quarter of 2014. Revenues were €190.6 million, up 4.4% compared to the second quarter of 2013.

July 30, 2014

CHICAGO--(BUSINESS WIRE)--Corgenix Medical Corporation has been recognized for outstanding research for its point-of-care Ebola test abstract presented today at the AACC Annual Meeting and Expo in Chicago.

July 30, 2014

NORWOOD, Mass.--(BUSINESS WIRE)--ADI’s new current-to-digital converter module doubles channel count while requiring 33 percent less real estate than alternative devices, plus mounts on standard PCB substrates.

July 30, 2014

EXTON, Pa.--(BUSINESS WIRE)--Tigermed and Frontage complete strategic investment agreement. Tigermed has acquired a majority position in Frontage's ownership for a full-service CRO partnership, from preclinical through late phase

July 30, 2014

LOS ANGELES--(BUSINESS WIRE)--BG Medical Technologies (OTC:RIGH) is developing training materials for physicians interested in learning more about recommending medical marijuana as part of health treatment programs.

July 30, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Announces Clinical Trial Agreement to Evaluate Combination of Two Novel Cancer Immunotherapies

July 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scott Minick, BIND’s President and CEO, will present at the Wedbush 2014 Life Sciences Management Access Conference in New York on Wednesday, August 13, 2014 at 10:55 a.m. ET

July 30, 2014

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company advancing NNR Therapeutics™, today announced it will report financial results for the second quarter of 2014 on Wednesday, August 6,...

July 30, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter today announced that it has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer Inc.

July 30, 2014

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited consolidated financial results for the quarter ended June 30, 2014 under International Financial Reporting Standards (IFRS). Key Highlights...

July 30, 2014

CHICAGO--(BUSINESS WIRE)--Chromatin, Inc., a leading producer of innovative crop breeding technology, sorghum seed products and feedstocks, today announced a collaborative sorghum feedstock program with Pacific Ethanol, Inc. (Nasdaq:PEIX),...

July 30, 2014

BOSTON--(BUSINESS WIRE)--Interactive Workforce Model Will Bring Invaluable New Data and Insight to Physician Shortage Debate

July 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea to announce second quarter 2014 financial results on August 6, 2014.

July 30, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced that it has entered into a definitive agreement to acquire Baxter International Inc.’s portfolio of marketed vaccines for $635 million. As part of the transaction, Pfizer will also acquire a...

July 30, 2014

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--The BioFlorida Conference will bring together 500+ life science professionals from FL and throughout the country attracting the largest and most prestigious life science community in the state.

July 30, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta to Host Conference Call and Webcast of Second Quarter 2014 Financial Results on August 6, 2014

July 30, 2014

SEATTLE--(BUSINESS WIRE)--Theraclone and Gilead enter into exclusive agreement for therapeutic applications for Theraclone's broadly neutralizing HIV antibodies.

July 30, 2014

ITINGEN, Switzerland--(BUSINESS WIRE)--Harlan Laboratories, Ltd. is prepared to meet the global demand for development programs in novel biologics and biosimilars.

July 30, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group (NYSE MKT: XXII) today announced that the U.S. Patent and Trademark Office granted a patent to the Company for its NBB technology to eliminate nicotine in the tobacco plant.

July 30, 2014

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. prices offering.

July 30, 2014

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions at the Annual General Meeting of the...

July 30, 2014

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30,...

July 30, 2014

KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--The Republic of Guinea is looking up to Malaysia’s expertise in the palm oil sector to boost the two nations’ bilateral trade ties, which was valued at US$45 million (RM143.10 million) last year, and the...

July 29, 2014

MADISON, Wis.--(BUSINESS WIRE)--NIH awards Imbed Bio a $1.5M grant to continue development of an advanced wound healing nanofilm dressing with silver nanoparticles that provides antimicrobial barrier in burns and chronic ulcers.

July 29, 2014

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. launches $40 million offering.

July 29, 2014

BOSTON--(BUSINESS WIRE)--Vertex Reports Second Quarter 2014 Financial Results and Provides Updates on Key Research and Development Programs

July 29, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2014. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and...

July 29, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Vantage Health (the “Company”) (OTCQB:VNTH) today announced the appointment of Kevin Buckman MD FAAIM, DAAUCM, MACOEM, MRO as Chairman and CEO of the Company. The Company also announced that Mr. Jeremy...

July 29, 2014

CHICAGO--(BUSINESS WIRE)--Fitch Ratings expects that revenues from biologic therapies as a percentage of total pharmaceutical sales will continue to increase over the intermediate term as companies increase their prominence in their drug...

July 29, 2014

WITTEN, Germany--(BUSINESS WIRE)--SanguiBioTech yields revenues of around USD42,000 in Q4 2014 according to preliminary figures

July 29, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Paris:MKEA) (NYSE Euronext: MKEA, FR0010609263), a leader in the optical biopsy market, announced today it has received 501(k) regulatory clearance from the United States Food and...

July 29, 2014

SAN MATEO, Calif.--(BUSINESS WIRE)--SmartStory™ Technologies announced it has deployed its groundbreaking SmartStory enterprise platform.

July 29, 2014

PHILADELPHIA--(BUSINESS WIRE)--Revitas Welcomes Cumberland Consulting Group as the Exclusive Diamond Sponsor for the 2014 Revitas Industry Summit: Life Sciences

July 29, 2014

PHOENIX--(BUSINESS WIRE)--Creative Medical Health, a biotechnology and bionutraceutical company, announces trademark approval in the U.S. and E.U. for its designation Bionutraceutical.

July 29, 2014

SUFFERN, N.Y.--(BUSINESS WIRE)--Genomics R&D firm, Ryogen LLC, received two U.S. Patents – its 31st and 32nd – that are directed to polynucleotide sequences that play critical roles in various cancers.

July 29, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth Expands U.S. Sales Team with Three Strategic New Hires

July 29, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea will report its financial results for the second quarter 2014, on Wednesday, August 6, 2014 before the market opens followed by a conference call with the investment community at 8:30 AM EDT.